Cargando…
Cardiovascular Biomarkers in Chronic Kidney Disease: State of Current Research and Clinical Applicability
The high incidence of cardiovascular events in chronic kidney disease (CKD) warrants an accurate evaluation of risk aimed at reducing the burden of disease and its consequences. The use of biomarkers to identify patients at high risk has been in use in the general population for several decades and...
Autores principales: | D'Marco, Luis, Bellasi, Antonio, Raggi, Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4402164/ https://www.ncbi.nlm.nih.gov/pubmed/25944976 http://dx.doi.org/10.1155/2015/586569 |
Ejemplares similares
-
Epicardial Adipose Tissue, Adiponectin and Leptin: A Potential Source of Cardiovascular Risk in Chronic Kidney Disease
por: D’Marco, Luis, et al.
Publicado: (2020) -
Cardiorenal Fat: A Cardiovascular Risk Factor With Implications in Chronic Kidney Disease
por: D'Marco, Luis, et al.
Publicado: (2021) -
Cardiovascular risk factors and the impact on prognosis in patients with chronic kidney disease secondary to autosomal dominant polycystic kidney disease
por: Gorriz, José Luis, et al.
Publicado: (2021) -
Chronic Kidney Disease: The Silent Epidemy
por: Bellasi, Antonio, et al.
Publicado: (2019) -
Epidemiology of low-proteinuric chronic kidney disease in renal clinics
por: De Nicola, Luca, et al.
Publicado: (2017)